Literature DB >> 10052880

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.

L Moonen1, H vd Voet, R de Nijs, A A Hart, S Horenblas, H Bartelink.   

Abstract

PURPOSE: To determine the relationship between tumour and patient characteristics and local control and survival for patients with T2 and T3 bladder cancer treated with radical external beam radiotherapy and to evaluate the predictive value of cystoscopic response evaluation during radiation on final outcome.
MATERIALS AND METHODS: Records from 379 patients with non-metastasized T2 or T3 transitional cell carcinoma of the bladder were reviewed. All patient received external beam radiotherapy at The Netherlands Cancer Institute during the period from 1977 to 1990. The total dose varied from 50 to 75 Gy with a mean of 60.5 Gy and a median of 60.4 Gy. The median follow-up was 22 months for all patients and 82 months for the 30 patients still alive at last follow-up. A stepwise procedure using proportional hazard regression was used to identify prognostic factors with respect to local recurrence and survival.
RESULTS: One hundred thirty-six patients experienced a local recurrence and 120 of these occurred before regional or distance metastases. The actuarial results at 5 years were 40.3% local control (SE 4.0%), 24.9% disease-free rate (SE 3.0%) and 22.2% overall survival (SE 2.2%). In the univariate analysis age, performance status, result of intravenous pyelography (IVP) and T-stage were found to be related to overall survival and multifocality was related to local control. Multivariate analysis revealed that only age and T-stage were related to survival and only multifocality was related to local control. In patients with solitary tumours who were identified as having the most favourable outcome. local control was 50% at 5 years. Local control in 89 patients who had a cystoscopic evaluation during treatment was identical regardless of whether a complete, partial or no response was observed. Furthermore, local control was identical in patients selected on the basis of a favourable response and in unselected patients.
CONCLUSIONS: Although we identified some significant prognostic factors, their predictive value is not strong enough to allow accurate estimation of treatment effect and disease outcome. Cystoscopic response evaluation during treatment was found not to provide reliable information to direct further treatment. Prospective studies to identify ways to select patients for bladder conservation using definitive radiotherapy are urgently needed.

Entities:  

Mesh:

Year:  1998        PMID: 10052880     DOI: 10.1016/s0167-8140(98)00089-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.

Authors:  Adnan El-Achkar; Luis Souhami; Wassim Kassouf
Journal:  Curr Urol Rep       Date:  2018-11-03       Impact factor: 3.092

Review 2.  Landmarks in the treatment of muscle-invasive bladder cancer.

Authors:  Niyati Lobo; Chloe Mount; Kawa Omar; Rajesh Nair; Ramesh Thurairaja; Muhammad Shamim Khan
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

Review 3.  Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer.

Authors:  Côme Tholomier; Luis Souhami; Wassim Kassouf
Journal:  Transl Androl Urol       Date:  2020-12

4.  Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder.

Authors:  B S Yadav; S Ghoshal; S C Sharma
Journal:  Indian J Urol       Date:  2008-01

5.  GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.

Authors:  P J Hoskin; A Sibtain; F M Daley; G D Wilson
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

Review 6.  Bladder Preservation for Muscle Invasive Bladder Cancer.

Authors:  Arafat Mirza; Ananya Choudhury
Journal:  Bladder Cancer       Date:  2016-04-27

7.  The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.

Authors:  Haruka Miyata; Takahiro Osawa; Takashige Abe; Hiroshi Kikuchi; Ryuji Matsumoto; Satoru Maruyama; Kentaro Nishioka; Shinichi Shimizu; Takayuki Hashimoto; Hiroki Shirato; Nobuo Shinohara
Journal:  Jpn J Clin Oncol       Date:  2020-05-05       Impact factor: 3.019

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.